Stereotactic body-radiotherapy boost dose of 18 Gy vs 21 Gy in combination with androgen-deprivation therapy and whole-pelvic radiotherapy for intermediate- or high-risk prostate cancer: a study protocol for a randomized controlled, pilot trial
Combination therapy using external-beam radiotherapy (EBRT) with a brachytherapy boost has demonstrated superior biochemical control than dose-escalated EBRT alone. Whereas brachytherapy is disadvantageous bec...
Source: Trials - Category: General Medicine Authors: Yeon Joo Kim, Hanjong Ahn, Choung-Soo Kim, Jae-Lyun Lee and Young Seok Kim Tags: Study protocol Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | External Beam Therapy | General Medicine | Prostate Cancer | Study